EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

ezCaretech Co. LTD (099750) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of ezCaretech Co. LTD KRW 2,781, price KRW 7,230, upside -61.5%, quality 47 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · KR · ISIN KR7099750002

EC Thin data Sep 24, 2026

ezCaretech Co. LTD

099750 · KQ

Weakest SetupStrongly overvalued and low quality.

!Fair value 2,781 KRW · Strongly overvalued (−62%)
!Quality 47/100
!Weak Growth (revenue 5y +0.5 %/yr)
!Thin margins · 7.7% net margin (TTM)
!negative free cash flow
✓Ranks above peers (5/7)
!Moderate moat 45/100
!Evidence only low, so the estimate is less certain
Watch ezCaretech Co. LTD for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

26,592 KRW 5,920 KRW Fair Value 2,781 KRW Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 5,920 KRW – 26,592 KRW · fair‑value band 2,506 KRW – 3,127 KRW · the 7,230 KRW price screens above the 2,781 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 24, 2026.

Follow ezCaretech Co. in your weekly email

Every Wednesday you see whether ezCaretech Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

ezCaretech Co., LTD engages in the provision of various modules for hospital operations in South Korea, Saudi Arabia, the United States, Japan, and internationally.

Show more

ezCaretech Co., LTD engages in the provision of various modules for hospital operations in South Korea, Saudi Arabia, the United States, Japan, and internationally. The company's solutions include BESTCare 2.0, an EMR/EHR solution that optimizes workflows, enhances patient safety and empowerment, minimizes workload for healthcare professionals, and ensures data sharing. It also offers Behavioral specialized HER, a solution for behavioral health; and Cloud HER, which provides a standardized system, security, and software maintenance. The company is headquartered in Seoul, South Korea.

Stock analysis

ezCaretech Co. LTD (099750) currently trades at 7,230 KRW, while our model-based Fair Value estimate is 2,781 KRW, implying the stock looks roughly 159.9% overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 8,186 KRW per share, and 5 of the 14 models we run sit above the 7,230 KRW price.

Bear case: the Asset-Based group reads lowest at 2,199 KRW, and 9 of the 14 models stay below the price. Evidence for this calculation is low.

Scenario range: 2,506 KRW (bear) to 3,127 KRW (bull), the price of 7,230 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

ezCaretech Co. LTD reported revenue of 78.9B KRW in FY2026 versus 92.1B KRW in FY2022, a compound −3.8%/yr. Reported net income was 6.1B KRW in FY2026.

Key figures

Market cap 98.7B KRW (≈ $72.5M) · P/S ratio 1.06 · Net margin 7.7% · Return on equity 15.0% · Return on assets (EBIT) −1.5% · Operating margin 6.6% · Revenue (TTM) 78.9B KRW · Revenue growth (YoY) +53.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades about 37% below its 52-week high and 22% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at −62%, 099750 screens richer than that median.

Fair Value models

Bear 2,506 KRW Fair Value 2,781 KRW Bull 3,127 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Owner Earnings 3,494 KRW 4,504 KRW 5,704 KRW 75
EPV 2,794 KRW 3,077 KRW 3,307 KRW 70
ROIC Compounder 2,794 KRW 3,077 KRW 3,320 KRW 70
All 14 models by family
DCF Models
Owner Earnings 3,494 KRW 4,504 KRW 5,704 KRW 75
Earnings-Based
Graham-Dodd 3,035 KRW 7,933 KRW 10,350 KRW 65
PEG = 1.0 1,512 KRW 2,160 KRW 2,808 KRW 57
EPV 2,794 KRW 3,077 KRW 3,307 KRW 70
Multiples
P/E Multiple 7,364 KRW 9,818 KRW 12,273 KRW 63
P/S Multiple 5,690 KRW 7,587 KRW 9,483 KRW 58
P/B Multiple 5,690 KRW 7,587 KRW 9,483 KRW 55
EV/EBIT 5,124 KRW 6,686 KRW 8,249 KRW 63
EV/EBITDA 5,269 KRW 6,881 KRW 8,492 KRW 64
EV/Revenue 3,781 KRW 5,215 KRW 6,650 KRW 51
Asset-Based
NCAV (Graham) 1,641 KRW 2,199 KRW 3,282 KRW 51
Economic Profit
Residual Income 2,845 KRW 3,227 KRW 5,088 KRW 69
ROIC Compounder 2,794 KRW 3,077 KRW 3,320 KRW 70
Growth Earnings
Growth-Adj P/E 5,730 KRW 8,186 KRW 10,642 KRW 67

Open the full fair value analysis →

Notify me when 099750 reaches fair value

Put 099750 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 47/100

Of which business quality 47 · Market factors (momentum, volatility) 36

Profitability 60
Margins and returns on capital today
Quality Growth 54
Are margins and returns improving?
Cashflow 6
Earnings quality: real cash, not paper profit
Fin. Strength 86
Balance sheet, leverage, solvency risk
Investment 78
Disciplined investing over empire-building
Low Volatility 65
Calm price path (market factor)
Momentum 26
Price trend over the last 3–12 months (market factor)
52W Momentum 19
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 31/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+8.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.5%
Start year 2021 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.5%
What shareholders gained per year (last 3 years), in KRW (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+57.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year+57.6%
Dividend (yield on the price)0.0%
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−12% → 6%
2026 sits 71% above its own trend. The rate follows the median trend of the last 3 years, not that single year.

099750 screens 160% overvalued. Compare with Veeva Systems Inc →

Compare ezCaretech Co. LTD with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 134 stocks

Beats the industry median on 5/7 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 47 · Below median
Fair Value upside −62% · Below median
Profitability
Return on equity (TTM) 15% · Top 25%
Return on assets 6% · Top 25%
Net margin (TTM) 8% · Above median
Operating margin (TTM) 7% · Above median
Growth and dividend
Revenue growth 54% · Top 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 3
FUTURE (revenue growth)100 · sector 34
PAST (return on equity)60 · sector 5
HEALTH (low debt)0 · sector 98
DIVIDEND (yield)0 · sector 48

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Veeva Systems Inc VEEV $270.75 $297.83 +10%
Pro Medicus Limited PME A$161.31 A$64.50 −60%
BrightSpring Health Services, Inc BTSG $56.55 $26.07 −54%
HealthEquity, Inc HQY $91.75 $100.93 +10%
Hinge Health, Inc HNGE $94.15 $51.66 −45%
10x Genomics, Inc TXG $80.70 $21.71 −73%
Waystar Holding WAY $25.63 $28.19 +10%
XtalPi Holdings 2228 HK$8.39 HK$1.50 −82%
Doximity, Inc DOCS $26.51 $31.41 +18%
Privia Health Group PRVA $19.46 $5.26 −73%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

ezCaretech Co. LTD · Fair Value
2,781 KRW −160%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "ezCaretech Co. LTD Fair Value". https://www.fairvalue-calculator.com/stock/099750

Frequently asked questions

Is ezCaretech Co. LTD (099750) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 2,781 KRW versus a price of 7,230 KRW, about −62% upside (overvalued).
What is the fair value of 099750?
Our model-based fair value for ezCaretech Co. LTD is 2,781 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 7,230 KRW.
What is the quality score of 099750?
ezCaretech Co. LTD has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for ezCaretech Co. LTD (099750)?
Our model-based price target is the fair value of 2,781 KRW (as of Sep 24, 2026) from 14 valuation models. Cautious scenario 2,506 KRW, optimistic scenario 3,127 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the ezCaretech Co. LTD stock forecast for 2026?
Our models put fair value at 2,781 KRW, about −62% upside versus a price of 7,230 KRW (overvalued). Cautious scenario 2,506 KRW, optimistic scenario 3,127 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of ezCaretech Co. LTD (099750)?
ezCaretech Co. LTD reported trailing-twelve-month revenue of about 78.9B KRW (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of ezCaretech Co. LTD (099750)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For ezCaretech Co. LTD it is 2,781 KRW per share (as of Sep 24, 2026), against a price of 7,230 KRW. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is ezCaretech Co. LTD stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 099750 trades above its calculated fair value: price 7,230 KRW, fair value 2,781 KRW, a gap of about −62% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 099750?
No. The price is what the market pays today (7,230 KRW); the fair value is what the company's own numbers justify (2,781 KRW). For ezCaretech Co. LTD the two are 4,449 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is ezCaretech Co. LTD worth?
The market values ezCaretech Co. LTD at about 98.7B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 7,230 KRW; our models calculate a fair value of 2,781 KRW per share.
What do the bullish and bearish scenarios say about 099750?
Our models span a range for ezCaretech Co. LTD: cautious scenario 2,506 KRW, base 2,781 KRW, optimistic 3,127 KRW per share (as of Sep 24, 2026, price 7,230 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of ezCaretech Co. LTD (099750)?
Balance-sheet figures for ezCaretech Co. LTD (as of Sep 24, 2026): return on equity 15.0%. They feed the Quality Score of 47/100, which measures business quality independently of the share price.
How far is 099750 from its 52-week high?
ezCaretech Co. LTD trades at 7,230 KRW, about 37% below its 52-week high of 11,450 KRW and 22% above the low of 5,920 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 2,781 KRW is for.
Which stocks are comparable to ezCaretech Co. LTD?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is ezCaretech Co. LTD stock attractive at the current price?
The data as of Sep 24, 2026: price 7,230 KRW, calculated fair value 2,781 KRW (−62%), Quality Score 47/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 099750 calculated?
We run ezCaretech Co. LTD through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 2,781 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. ezCaretech Co. LTD itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of ezCaretech Co. LTD (099750)?
The closing price on Sep 23, 2026 was 7,230 KRW. Our model-based fair value is 2,781 KRW, about −62% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with ezCaretech Co. LTD right now?
The price sits above even our optimistic bull case (3,127 KRW). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of ezCaretech Co. LTD

How large is the market capitalisation of ezCaretech Co. LTD (099750)?
The market capitalisation of ezCaretech Co. LTD is 98.7B KRW (≈ $72.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of ezCaretech Co. LTD (099750)?
The price-to-sales ratio of ezCaretech Co. LTD is 1.06 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of ezCaretech Co. LTD (099750)?
The net margin of ezCaretech Co. LTD is 7.7% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of ezCaretech Co. LTD (099750)?
The return on equity (ROE) of ezCaretech Co. LTD is 15.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of ezCaretech Co. LTD (099750)?
On an EBIT basis the return on assets of ezCaretech Co. LTD is −1.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of ezCaretech Co. LTD (099750)?
The operating margin of ezCaretech Co. LTD is 6.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at ezCaretech Co. LTD (099750)?
Revenue at ezCaretech Co. LTD is growing +53.8% versus a year earlier (3y avg +2.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at ezCaretech Co. LTD (099750)?
Earnings per share at ezCaretech Co. LTD are growing +4.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does ezCaretech Co. LTD (099750) generate?
The free cash flow of ezCaretech Co. LTD is −3.5B KRW (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch ezCaretech Co. LTD in the live analysis

One click puts ezCaretech Co. LTD on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.